Khaled Bahi
Finanzdirektor/CFO bei ONWARD MEDICAL N.V.
Profil
Khaled Bahi is currently the Chief Financial Officer at Onward Medical NV.
Previously, he held the position of Chief Financial Officer at Symetis SA from 2014 to 2019.
He also worked as the Chief Financial Officer at Stilla Technologies SA. Mr. Bahi is a graduate of the Swiss Federal Institute of Technology.
Aktive Positionen von Khaled Bahi
| Unternehmen | Position | Beginn |
|---|---|---|
| ONWARD MEDICAL N.V. | Finanzdirektor/CFO | 01.10.2023 |
Ehemalige bekannte Positionen von Khaled Bahi
| Unternehmen | Position | Ende |
|---|---|---|
| SYMETIS SA | Finanzdirektor/CFO | 01.10.2019 |
Stilla Technologies SA
 Stilla Technologies SA Miscellaneous Commercial ServicesCommercial Services Stilla Technologies SA operates as a biotechnology company that focuses on the development genetic tests. It provides crystal digital PCR, a next-generation technology for absolute quantification of nucleic acids. The company was founded by Remi Dangla, Etienne Fradet and Clement Gay in 2013 and is headquartered in Villejuif, France. | Finanzdirektor/CFO | - |
Ausbildung von Khaled Bahi
| Swiss Federal Institute of Technology | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ONWARD MEDICAL N.V. | Commercial Services |
| Private Unternehmen | 2 |
|---|---|
Symetis SA
 Symetis SA BiotechnologyHealth Technology Symetis SA develops minimally invasive heart valve replacement devices. Its products include ACURATE TA and ACURATE neo. The company was founded by Simon P. Hoerstrup and Gregor Zünd on September 5, 2001 and is headquartered in Ecublens, Switzerland. | Health Technology |
Stilla Technologies SA
Stilla Technologies SA Miscellaneous Commercial ServicesCommercial Services Stilla Technologies SA operates as a biotechnology company that focuses on the development genetic tests. It provides crystal digital PCR, a next-generation technology for absolute quantification of nucleic acids. The company was founded by Remi Dangla, Etienne Fradet and Clement Gay in 2013 and is headquartered in Villejuif, France. | Commercial Services |
